Integrin Imaging to Evaluate Treatment Response

Integrin Imaging to Evaluate Treatment Response

Despite the recent development of various radiolabelled RGD peptides for imaging the αvβ3 integrin receptor, relatively little attention has been focused on the ability of these radiotracers to monitor changes in tumour vascularity following treatment with anti-tumour therapies. Here we describe the favourable in vivo kinetics and tumour targeting properties of several novel radiolabeled RGD co...

Molecular imaging metrics to evaluate response to preclinical therapeutic regimens.

Molecular imaging comprises a range of techniques, spanning not only several imaging modalities but also many disease states and organ sites. While advances in new technology platforms have enabled a deeper understanding of the cellular and molecular basis of malignancy, reliable non-invasive imaging metrics remain an important tool for both diagnostics and patient management. Furthermore, the ...

T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma.

BACKGROUND AND PURPOSE T2-weighted MRI shows potential in early posttreatment assessment of the primary tumor. Residual masses composed entirely of low T2-signal scar tissue suggest local control and those ≥1 cm of similar signal to untreated tumor suggest local failure. The purpose of this study was to investigate the diagnostic accuracy of T2-weighted MR imaging early after chemoradiotherapy ...

Using Imaging Technology to Evaluate Highway Safety

A Method to Evaluate Response Models

We are working towards computational models of mind of virtual characters that act as suspects in interview (interrogation) training of police officers. We implemented a model that calculates the responses of the virtual suspect based on theory and observation. We evaluated it by means of our test, the “Guess who you are talking to?” test. We show that this test can contribute to building respo...